Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma

Roland Kaelin; Giorgia Mastrella; Mengzhuo Hou; Min Li; Veit Stoecklein; Nina Zdouc; Marie Volmar; Hrvoje Miletic; Soeren Reinhard; Christel Herold-Mende; Susanne Kleber; Katharina Eisenhut; Gaetano Gargiulo; Michael Synowitz; Angelo Vescovi; Patrick Harter; Josef Penninger; Ernst Wagner; Michel Mittelbronn; Rolf Bjerkvig; Dolores Hambardzumyan; Ulrich Schueller; Joerg-Christian Tonn; Josefine Radke; Rainer Glass

doi:10.1093/neuonc/noz175.114

Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma

Roland Kaelin, Giorgia Mastrella, Mengzhuo Hou, Min Li, Veit Stoecklein, Nina Zdouc, Marie Volmar, Hrvoje Miletic, Soeren Reinhard, Christel Herold-Mende, Susanne Kleber, Katharina Eisenhut, Gaetano Gargiulo, Michael Synowitz, Angelo Vescovi, Patrick Harter, Josef Penninger, Ernst Wagner, Michel Mittelbronn, Rolf BjerkvigDolores Hambardzumyan, Ulrich Schueller, Joerg-Christian Tonn, Josefine Radke, Rainer Glass

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	30-30
DOIs	https://doi.org/10.1093/neuonc/noz175.114
Publication status	Published - Nov 2019
Event	24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS - Phoenix, Arizona, United States Duration: 22 Nov 2019 → 24 Nov 2019

Conference

Conference	24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS
Country/Territory	United States
City	Phoenix, Arizona
Period	22/11/19 → 24/11/19

Access to Document

10.1093/neuonc/noz175.114Licence: Unspecified

Cite this

Kaelin, R., Mastrella, G., Hou, M., Li, M., Stoecklein, V., Zdouc, N., Volmar, M., Miletic, H., Reinhard, S., Herold-Mende, C., Kleber, S., Eisenhut, K., Gargiulo, G., Synowitz, M., Vescovi, A., Harter, P., Penninger, J., Wagner, E., Mittelbronn, M., ... Glass, R. (2019). Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma. 30-30. Abstract from 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS, Phoenix, Arizona, United States. https://doi.org/10.1093/neuonc/noz175.114

Kaelin, Roland ; Mastrella, Giorgia ; Hou, Mengzhuo et al. / Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma. Abstract from 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS, Phoenix, Arizona, United States.

@conference{99253992cf564ffcbab13b522d326107,

title = "Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma",

author = "Roland Kaelin and Giorgia Mastrella and Mengzhuo Hou and Min Li and Veit Stoecklein and Nina Zdouc and Marie Volmar and Hrvoje Miletic and Soeren Reinhard and Christel Herold-Mende and Susanne Kleber and Katharina Eisenhut and Gaetano Gargiulo and Michael Synowitz and Angelo Vescovi and Patrick Harter and Josef Penninger and Ernst Wagner and Michel Mittelbronn and Rolf Bjerkvig and Dolores Hambardzumyan and Ulrich Schueller and Joerg-Christian Tonn and Josefine Radke and Rainer Glass",

note = "Neuro-Oncology Volume: 21 Issue number: Suppl.6 Pages (from-to): 30-30 Article number: ANGI-03 ; 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS ; Conference date: 22-11-2019 Through 24-11-2019",

year = "2019",

month = nov,

doi = "10.1093/neuonc/noz175.114",

language = "English",

pages = "30--30",

}

Kaelin, R, Mastrella, G, Hou, M, Li, M, Stoecklein, V, Zdouc, N, Volmar, M, Miletic, H, Reinhard, S, Herold-Mende, C, Kleber, S, Eisenhut, K, Gargiulo, G, Synowitz, M, Vescovi, A, Harter, P, Penninger, J, Wagner, E, Mittelbronn, M , Bjerkvig, R, Hambardzumyan, D, Schueller, U, Tonn, J-C, Radke, J & Glass, R 2019, 'Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma', 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS, Phoenix, Arizona, United States, 22/11/19 - 24/11/19 pp. 30-30. https://doi.org/10.1093/neuonc/noz175.114

Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma. / Kaelin, Roland; Mastrella, Giorgia; Hou, Mengzhuo et al.

2019. 30-30 Abstract from 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS, Phoenix, Arizona, United States.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma

AU - Kaelin, Roland

AU - Mastrella, Giorgia

AU - Hou, Mengzhuo

AU - Li, Min

AU - Stoecklein, Veit

AU - Zdouc, Nina

AU - Volmar, Marie

AU - Miletic, Hrvoje

AU - Reinhard, Soeren

AU - Herold-Mende, Christel

AU - Kleber, Susanne

AU - Eisenhut, Katharina

AU - Gargiulo, Gaetano

AU - Synowitz, Michael

AU - Vescovi, Angelo

AU - Harter, Patrick

AU - Penninger, Josef

AU - Wagner, Ernst

AU - Mittelbronn, Michel

AU - Bjerkvig, Rolf

AU - Hambardzumyan, Dolores

AU - Schueller, Ulrich

AU - Tonn, Joerg-Christian

AU - Radke, Josefine

AU - Glass, Rainer

N1 - Neuro-Oncology Volume: 21 Issue number: Suppl.6 Pages (from-to): 30-30 Article number: ANGI-03

PY - 2019/11

Y1 - 2019/11

U2 - 10.1093/neuonc/noz175.114

DO - 10.1093/neuonc/noz175.114

M3 - Abstract

SP - 30

EP - 30

T2 - 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

Y2 - 22 November 2019 through 24 November 2019

ER -

Kaelin R, Mastrella G, Hou M, Li M, Stoecklein V, Zdouc N et al.. Pharmacological targeting of apelin/aplnr signaling blunts therapy resistance to VEGFA/VEGFR2 anti-angiogenic treatment in glioblastoma. 2019. Abstract from 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS, Phoenix, Arizona, United States. doi: 10.1093/neuonc/noz175.114